Updated Jul 16, 2026
Woo Raymond has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.70M.
Raymond Woo is the Chief Technology Officer at Ceribell, Inc., a medical technology company focused on improving the diagnosis and management of neurological conditions. He has been involved in the development of the Ceribell System, which utilizes advanced technology for point-of-care EEG.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-26 | CBLL | Ceribell, Inc. | S — Open-market sale | 2.0K | $18.00 | $35K |
| 2026-05-04 | CBLL | Ceribell, Inc. | S — Open-market sale | 6.6K | $20.45 | $135K |
| 2026-05-04 | CBLL | Ceribell, Inc. | M — Option exercise | 6.6K | $4.70 | $31K |
| 2026-05-04 | CBLL | Ceribell, Inc. | S — Open-market sale | 3.0K | $20.43 | $62K |
| 2026-05-04 | CBLL | Ceribell, Inc. | M — Option exercise | 3.0K | $4.70 | $14K |
| 2026-05-04 | CBLL | Ceribell, Inc. | S — Open-market sale | 1.5K | $20.39 | $30K |
| 2026-05-04 | CBLL | Ceribell, Inc. | M — Option exercise | 1.5K | $2.24 | $3K |
| 2026-04-03 | CBLL | Ceribell, Inc. | A — Grant or award [10b5-1] | 30.7K | $0.00 | |
| 2026-04-03 | CBLL | Ceribell, Inc. | S — Open-market sale [10b5-1] | 6.6K | $18.57 | $123K |
| 2026-04-03 | CBLL | Ceribell, Inc. | M — Option exercise [10b5-1] | 6.6K | $4.70 | $31K |
| 2026-04-03 | CBLL | Ceribell, Inc. | S — Open-market sale [10b5-1] | 3.0K | $18.53 | $56K |
| 2026-04-03 | CBLL | Ceribell, Inc. | M — Option exercise [10b5-1] | 3.0K | $4.70 | $14K |
| 2026-04-03 | CBLL | Ceribell, Inc. | S — Open-market sale [10b5-1] | 1.5K | $18.58 | $27K |
| 2026-04-03 | CBLL | Ceribell, Inc. | M — Option exercise [10b5-1] | 1.5K | $2.24 | $3K |
| 2026-03-04 | CBLL | Ceribell, Inc. | S — Open-market sale [10b5-1] | 6.6K | $18.25 | $121K |
| 2026-03-04 | CBLL | Ceribell, Inc. | M — Option exercise [10b5-1] | 6.6K | $4.70 | $31K |
| 2026-03-04 | CBLL | Ceribell, Inc. | S — Open-market sale [10b5-1] | 3.0K | $18.26 | $55K |
| 2026-03-04 | CBLL | Ceribell, Inc. | M — Option exercise [10b5-1] | 3.0K | $4.70 | $14K |
| 2026-03-04 | CBLL | Ceribell, Inc. | S — Open-market sale [10b5-1] | 1.5K | $18.26 | $27K |
| 2026-03-04 | CBLL | Ceribell, Inc. | M — Option exercise [10b5-1] | 1.5K | $2.24 | $3K |
Raymond Woo is the Chief Technology Officer at Ceribell, Inc., a medical technology company focused on improving the diagnosis and management of neurological conditions. He has been involved in the development of the Ceribell System, which utilizes advanced technology for point-of-care EEG.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 21 open-market sales ($1.70M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Woo Raymond profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.